Ajan Reginald
@AjanReginald
Followers
7K
Following
6K
Media
493
Statuses
5K
Entrepreneur & CEO Cardiogeni PLC @Celixirltd. ExBCG and Roche. Fulbright Scholar, Uni of Oxford, Harvard Business School and Kellogg. Personal opinions
Oxford, England
Joined September 2012
They did an 8000 patient clinical trial at a cost of just $1.3 million by incorporating the trial into routine clinical practice. #ASH25 Traction trial. Would have cost >100 times more ordinarily. We need to completely revamp the clinical trial bureaucracy.
9
56
300
Scientists have uncovered how #leukaemia cells โcheat deathโ; rewiring their mitochondria to evade one of todayโs most effective treatments. The discovery could lead to new ways to defeat drug-resistant leukemia. #TCSC #Leukemia #Oncology #Cancer #Cells
scitechdaily.com
Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists from Rutgers Health and collaborating institutions have uncovered why a...
0
1
1
Varsity (Ivy League) athletes earn 3.4% more over their entire careers, and attain more senior positions than their classmates despite entering college with lower academic qualifications
How does undergraduate participation in varsity sports enhance career success? @HarvardHBS's Paul Gompers โ86, Ph.D. โ93, and colleagues at the @nberpubs compared the careers of Ivy League varsity athletes to those of their non-athlete classmates. #Harvard
https://t.co/VaY7n8kktt
0
0
1
Great discussion at this 2025 Evolution conference on innovation in BioPharma https://t.co/qeLN9GNb9W
linkedin.com
โจ๐๐ฎ๐ฌ๐ญ ๐ฐ๐ซ๐๐ฉ๐ฉ๐๐ ๐ฎ๐ฉ ๐๐ง๐จ๐ญ๐ก๐๐ซ ๐๐๐ง๐ญ๐๐ฌ๐ญ๐ข๐ ๐๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ฎ๐ซ๐จ๐ฉ๐ ๐๐ฎ๐ฆ๐ฆ๐ข๐ญ ๐ข๐ง ๐๐จ๐ง๐ญ๐ซ๐๐ฎ๐ฑ, ๐๐ฐ๐ข๐ญ๐ณ๐๐ซ๐ฅ๐๐ง๐! Two inspiring days with senior clinical...
0
0
2
'Talent is everywhere, but opportunity is not. Except at Oxford.' VC Prof Irene Tracey shares what she wants the University to be remembered for. Read the Vice-Chancellorโs Oration in full โฌ๏ธ
32
89
414
Roquefort Therapeutics CEO Ajan Reginald on strategic asset sale to Pleiades Pharma @RoquefortTherap #LSE #ROQ
2
6
8
$10m Pleiades deal signed. Details in RNS and Proactive interview to follow
1
5
9
๐ฅ Our CEO @AjanReginald talks with Stephen Gunnion from @proactive_UK on the transformational proposed sale of our Midkine portfolio to Pleiades Pharma Ltd #ROQ #Midkine #biotech
https://t.co/YAyHNYcSvd
0
7
7
โฆโฆโฆ@RoquefortTherapโฉ RNS re: sale of Lyramid subsidiary #ROQ
2
8
8
Roquefort Therapeutics - STAT-6 siRNA Presentation at Advanced Therapy Development Congress #ROQ #siRNA #STAT6
https://t.co/zGsYW5KpXg
1
8
10
$ROQ Roquefort presentation reveals the biotech is a leader in emerging targeted treatment field https://t.co/ERx7iJ2GPY
@roqueforttherap $ROQAF #ROQ #ROQAF
0
13
14
๐ฅ Our CEO @AjanReginald with Steve Darling from @proactive_UK on the promising results of our STAT-6 siRNA program #ROQ #Cancer #siRNA
https://t.co/H5aYXijQIH
2
13
15
Back in 2014, Novartis ditched its RNAi research, giving the lead scientist the first "courage award" for stopping bad projects!๐คฆโโ๏ธ Novartis ex-CEO Joseph Jimenez said at the time, "One of the reasons why spending in the pharmaceutical industry is so high is that many scientists
16
44
294
Roquefort Therapeutics is pleased to announce its interim results for the six-month period ended 30 June 2024 https://t.co/K9IxFr1iZl
0
4
10